PremiumCompany AnnouncementsHeartBeam’s Earnings Call Highlights Strategic Progress HeartBeam Advances Cardiac Care with FDA Clearance and New Innovations HeartBeam announces FDA clearance for high-fidelity ECG system PremiumThe FlyHeartBeam says Robert Eno appointed Chief Executive Officer, effective Oct 21 HeartBeam appoints Lance Myers chief artificial intelligence scientist HeartBeam Appoints New CFO to Bolster Financial Strategy PremiumCompany AnnouncementsHeartBeam Engages Public Ventures for Stock Sales, Ends Prior Agreement HeartBeam presents results on AI capabilities for detecting arrhythmias HeartBeam reports FY23 EPS (72c), consensus (76c) 
